Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Molina Healthcare (MOH) and Roche Holding AG (OtherRHHVF)

Tipranks - Tue Feb 10, 12:50AM CST

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Molina Healthcare (MOHResearch Report) and Roche Holding AG (RHHVFResearch Report).

Valentine's Day Sale - 70% Off

Molina Healthcare (MOH)

In a report released yesterday, Ryan Langston from TD Cowen reiterated a Hold rating on Molina Healthcare, with a price target of $144.00. The company’s shares closed last Friday at $131.72.

According to TipRanks.com, Langston is ranked 0 out of 5 stars with an average return of -9.2% and a 33.9% success rate. Langston covers the Healthcare sector, focusing on stocks such as Alignment Healthcare, Privia Health Group, and P3 Health Partners. ;'>

Currently, the analyst consensus on Molina Healthcare is a Hold with an average price target of $185.30, a 47.1% upside from current levels. In a report issued on February 7, TipRanks – OpenAI also downgraded the stock to Hold with a $130.00 price target.

See the top stocks recommended by analysts >>

Roche Holding AG (RHHVF)

In a report released today, Graham Parry from Citi maintained a Buy rating on Roche Holding AG, with a price target of CHF400.00. The company’s shares closed last Friday at $460.30.

Parry has an average return of 3.8% when recommending Roche Holding AG. ;'>

According to TipRanks.com, Parry is ranked #6552 out of 12104 analysts.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Roche Holding AG with a $444.37 average price target, a -0.6% downside from current levels. In a report issued on January 30, TipRanks – Google also upgraded the stock to Buy with a CHF404.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.